Appentra
Seed Round in 2023
Appentra Solutions, S.L. specializes in developing software tools that facilitate guided parallelization, targeting the democratization of high-performance computing across various fields, including engineering and science. Founded in 2012 and based in Corunna, Spain, the company offers several key products, including Parallware Trainer, a real-time interactive editor designed to enhance the teaching and application of parallel programming, and Parallelware Analyzer, a suite of command-line tools that assist developers in efficiently creating high-quality parallel software. As the demand for advanced computing capabilities grows, Appentra aims to simplify parallel programming, making it accessible to a broader range of organizations. Their innovative Parallelware technology, which focuses on static code analysis for concurrency and parallelism, positions the company as a leader in the shift towards mainstream adoption of parallel computing solutions.
Aerocámaras
Venture Round in 2022
Aerocamaras is a company focused on training and providing professional services related to drones and unmanned aerial vehicles (UAV) across 14 countries. It operates 20 drone pilot training centers in Spain, including two specialized centers for emergency and safety pilot training. The company offers a range of courses designed for various professional applications, including technical inspections, security, precision agriculture, and audiovisual production. Aerocamaras also develops customized drones, including a unique hybrid model that boasts over four hours of flight autonomy. In addition to training, the company sells drones from leading brands such as DJI and YUNEEC, catering to a diverse array of sectors like television, cinema, advertising, and industrial inspections.
Oncostellae
Venture Round in 2022
Founded in 2013 by researchers specializing in drug development, Oncostellae focuses on discovering and developing small molecule drugs for cancer treatment. The company manages its R&D process with a lean team, concentrating on project management, medicinal chemistry, and in vitro pharmacology while outsourcing other activities to qualified providers. Its strategic goal is to license a clinical drug candidate to a pharmaceutical or biotechnology company.
Coinscrap Finance
Venture Round in 2021
Coinscrap Finance S.L., established in 2016 and headquartered in Pontevedra, Spain, operates a mobile application that facilitates saving for millennials by rounding up card transactions and allocating the difference to secure savings products. The company's AI-powered recommendation engine enables banks and insurers to offer personalized digital experiences, enhancing customer understanding and facilitating tailored product offerings.
Origo Biopharma
Seed Round in 2020
Origo Biopharma S.L. is a biotechnology company founded in 2017 and headquartered in San Cibrao das Viñas, Spain. The company focuses on the research and development of immunotherapeutic products aimed at treating severe diseases associated with TGF-β signaling dysfunction, including cancer and fibrosis. By developing organ-restricted drugs, Origo Biopharma seeks to address unmet medical needs in these areas, providing potential cures for debilitating health conditions.
Appentra
Seed Round in 2020
Appentra Solutions, S.L. specializes in developing software tools that facilitate guided parallelization, targeting the democratization of high-performance computing across various fields, including engineering and science. Founded in 2012 and based in Corunna, Spain, the company offers several key products, including Parallware Trainer, a real-time interactive editor designed to enhance the teaching and application of parallel programming, and Parallelware Analyzer, a suite of command-line tools that assist developers in efficiently creating high-quality parallel software. As the demand for advanced computing capabilities grows, Appentra aims to simplify parallel programming, making it accessible to a broader range of organizations. Their innovative Parallelware technology, which focuses on static code analysis for concurrency and parallelism, positions the company as a leader in the shift towards mainstream adoption of parallel computing solutions.
Appentra
Pre Seed Round in 2017
Appentra Solutions, S.L. specializes in developing software tools that facilitate guided parallelization, targeting the democratization of high-performance computing across various fields, including engineering and science. Founded in 2012 and based in Corunna, Spain, the company offers several key products, including Parallware Trainer, a real-time interactive editor designed to enhance the teaching and application of parallel programming, and Parallelware Analyzer, a suite of command-line tools that assist developers in efficiently creating high-quality parallel software. As the demand for advanced computing capabilities grows, Appentra aims to simplify parallel programming, making it accessible to a broader range of organizations. Their innovative Parallelware technology, which focuses on static code analysis for concurrency and parallelism, positions the company as a leader in the shift towards mainstream adoption of parallel computing solutions.
Health In Code
Series A in 2012
Health In Code, S.L. is a company based in A Coruña, Spain, that specializes in genetic diagnosis for familial cardiac diseases. It provides molecular genetic diagnostic services aimed at the prognosis and treatment of hereditary cardiomyopathies, such as hypertrophic cardiomyopathy, dilated cardiomyopathy, and various channelopathies. In addition to cardiovascular conditions, Health In Code has expanded its focus to include other areas, such as oncology, neurology, and dyslipidemias. The company utilizes advanced knowledge management tools and a multidisciplinary team of experts to deliver high-quality sequencing services and the interpretation of genetic tests. This approach enables clinicians to offer personalized medical care and supports the development of tailored databases containing clinical and genetic information for individual patient management. As a leader in Europe for genetic diagnosis of inherited cardiovascular diseases, Health In Code is dedicated to enhancing diagnostic capabilities and improving patient outcomes through its innovative services.